Skip to main content
. 2020 Oct 15;6(12):1–9. doi: 10.1001/jamaoncol.2020.4643

Table 1. Characteristics of 97 Patients Evaluable for Efficacy.

Characteristic No. (%)
Age, median (range), y 64 (21-81)
Male 48 (49.5)
Female 49 (50.5)
ECOG performance status
0 34 (35.1)
1 54 (55.7)
2 9 (9.2)
Histology
Adenocarcinoma 51 (52.6)
Poorly differentiated adenocarcinoma 16 (16.5)
Undifferentiated carcinoma 15 (15.5)
Squamous cell carcinoma 9 (9.3)
Other 6 (6.2)

Abbreviation: ECOG, Eastern Cooperative Oncology Group.